Basit öğe kaydını göster

dc.contributor.authorDemirkiran, F
dc.contributor.authorOz, AU
dc.contributor.authorArvas, M
dc.contributor.authorBese, T
dc.contributor.authorErkun, E
dc.contributor.authorKosebay, D
dc.date.accessioned2021-03-05T08:51:51Z
dc.date.available2021-03-05T08:51:51Z
dc.date.issued1997
dc.identifier.citationBese T., Demirkiran F., Arvas M., Oz A., Kosebay D., Erkun E., "What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?", INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.7, ss.42-45, 1997
dc.identifier.issn1048-891X
dc.identifier.othervv_1032021
dc.identifier.otherav_9b0fc8fc-ff5a-4913-ba88-0a7bda211a41
dc.identifier.urihttp://hdl.handle.net/20.500.12627/104235
dc.identifier.urihttps://doi.org/10.1046/j.1525-1438.1997.00422.x
dc.description.abstractTo assess the predictive value of serum CA125 level prior to second-look laparotomy in epithelial ovarian carcinoma, 45 patients who were clinically or radiologically tumor-free prior to a second-look laparotomy were studied. Serum CA125 levels were measured 10 days prior to the operation, and were compared with the surgico-pathological results. Twenty-eight (62%) patients were found to have tumor at surgery. The serum CA125 levels were greater than or equal to 35 Uml(-1) (42%) patients. Tumors were found in 14 (74%) of these 19 patients. Although a serum CA125 level greater than or equal to 35 Uml(-1) was a strong predictor of the presence of an intraperitoneal tumor, a level < 35 U ml(-1) was not predictive of a tumor-free state. When the cut-off level was accepted as 20 U ml(-1), 28 patients (62%) were found to have elevated CA125 level. The sensitivity, the specificity, the positive and negative predictive value and the false negative ratio were calculated as 79%, 65%, 79%, 65% and 21% respectively. The threshold value for a raised CA125 level was considered and a lower level of 20 Uml(-1) was suggested as a cut-off level prior to second-look laparotomy in evaluating patients with known epithelial ovarian cancer.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectONKOLOJİ
dc.titleWhat should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
dc.contributor.department, ,
dc.identifier.volume7
dc.identifier.issue1
dc.identifier.startpage42
dc.identifier.endpage45
dc.contributor.firstauthorID118306


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster